Nebivolol: a review of its use in the management of hypertension and chronic heart failure
MD Moen, AJ Wagstaff - Drugs, 2006 - Springer
Nebivolol is a third-generation β-adrenoceptor antagonist. It differs from other β-
adrenoceptor antagonists as it combines highly selective β 1-adrenoceptor antagonist …
adrenoceptor antagonists as it combines highly selective β 1-adrenoceptor antagonist …
Heart failure in the elderly
M Chan, R Tsuyuki - Current opinion in cardiology, 2013 - journals.lww.com
Heart failure in the elderly : Current Opinion in Cardiology Heart failure in the elderly : Current
Opinion in Cardiology Log in or Register Subscribe to journalSubscribe Get new issue …
Opinion in Cardiology Log in or Register Subscribe to journalSubscribe Get new issue …
Effect of β-Blockers on β3-Adrenoceptor Expression in Chronic Heart Failure
Q Zhao, TG Wu, ZF Jiang, GW Chen, Y Lin… - … drugs and therapy, 2007 - Springer
Objectives To investigate the expression of β 3-adrenoceptors in rats with chronic heart
failure, and to explore the effect of β-blockers on β 3-adrenoceptor expression. Materials and …
failure, and to explore the effect of β-blockers on β 3-adrenoceptor expression. Materials and …
Nebivolol lowers blood pressure and increases weight loss in patients with hypertension and diabetes in regard to age
D Ladage, C Reidenbach, E Rieckeheer… - Journal of …, 2010 - journals.lww.com
Background: In patients with diabetes mellitus type 2 and arterial hypertension, the control of
systolic and diastolic blood pressure is essential to reduce the risk of adverse events. The …
systolic and diastolic blood pressure is essential to reduce the risk of adverse events. The …
Drug interactions in Parkinson's disease: safety of pharmacotherapy for arterial hypertension
A Bitner, P Zalewski, JJ Klawe, JL Newton - Drugs-Real World Outcomes, 2015 - Springer
Background Parkinson's disease (PD) is a progressive neurodegenerative disorder of the
central nervous system, observed in patients aged older than 50 years. In this study, we …
central nervous system, observed in patients aged older than 50 years. In this study, we …
Use of β-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues
MR Andrus, JV Loyed - Drugs & aging, 2008 - Springer
The incidence of and mortality from both chronic obstructive pulmonary disease (COPD) and
cardiovascular disease (CVD) increase with age. In addition, the average age of patients …
cardiovascular disease (CVD) increase with age. In addition, the average age of patients …
Is the Use of β-Blockers in COPD Still an Unresolved Dilemma?
A Foresi, G Cavigioli, G Signorelli, MB Pozzoni… - Respiration, 2010 - karger.com
Abstract β-Blockers are competitive antagonists at β-adrenergic receptors (β-AR) and are a
life-saving form of treatment in different cardiovascular diseases (CVD). Despite current …
life-saving form of treatment in different cardiovascular diseases (CVD). Despite current …
老年慢性心力衰竭药物治疗
雷小红， 徐业成， 邓万俊 - 心血管病学进展, 2008 - cqvip.com
老年慢性心力衰竭药物治疗-[维普官方网站]-www.cqvip.com-维普网 我的维普 购物车 充值 客服
首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线分享 | 学者空间 | 学术机构 您 …
首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线分享 | 学者空间 | 学术机构 您 …
Cardiology: Treatment of Systolic Heart Failure in the Elderly: An Evidence-Based Review
SA Arif, KA Mergenhagen… - Annals of …, 2010 - journals.sagepub.com
Objective: To review relevant literature supporting the use of β-blockers, angiotensin-
converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), diuretics …
converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), diuretics …
Insuffisance cardiaque du sujet jeune: aspect épidemio-clinique, étiologique et thérapeutique
HB Mohamed - 2019 - library.adhl.africa
Nous avons réalisé une étude transversale, s' étendant de Janvier 2018 à Décembre 2018
dans le service de cardiologie du CHU Point G soit 12 mois. Notre objectif principal était de …
dans le service de cardiologie du CHU Point G soit 12 mois. Notre objectif principal était de …